- AXLA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Axcella Health (AXLA) CORRESPCorrespondence with SEC
Filed: 10 Jun 20, 12:00am
June 10, 2020
Via EDGAR Transmission
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Axcella Health Inc.: Registration Statement on Form S-3 filed on June 5, 2020 (File No. 333-238983) |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Axcella Health Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to June 12, 2020, at 4:01 pm Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
If you have any questions regarding this request, please contact Laurie Burlingame of Goodwin Procter LLP at (617) 570-1879 or John Mei of Goodwin Procter LLP at (617) 570-1446.
Sincerely, | |
Axcella Health Inc. | |
/s/ Laurent Chardonnet | |
Laurent Chardonnet | |
Chief Financial Officer |
cc: | William Hinshaw, Axcella Health Inc. |
Kingsley L. Taft, Esq., Goodwin Procter LLP | |
Laurie A. Burlingame, Esq., Goodwin Procter LLP |